Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors.

Claire Banwell, Laura O'Neill, MR Uskokovic, Moray Campbell

Research output: Contribution to journalArticle

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors.'. Together they form a unique fingerprint.

Medicine & Life Sciences